Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population


Kahraman D. C. , Kahraman T., ATALAY R.

EACR 27, 1 - 04 Temmuz 2016, cilt.61, ss.77